Different effects of low muscle mass on the risk of non‐alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

(2021) Daniel Taliun et al.   NATURE

Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey

(2021) Joon Ho Moon et al.   Journal of Cachexia Sarcopenia and Muscle

Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis

(2021) Alessandro Mantovani et al.   Lancet Gastroenterology & Hepatology

2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea

(2021) Bo-Yeon Kim et al.   Journal of Obesity & Metabolic Syndrome

Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle : update 2021

(2021) Stephan Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

NAFLD 2020: The State of the Disease

(2020) Thomas G. Cotter et al.   GASTROENTEROLOGY

Association between muscle strength and advanced fibrosis in non‐alcoholic fatty liver disease: a Korean nationwide survey

(2020) Sunyoung Kang et al.   Journal of Cachexia Sarcopenia and Muscle

Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease

(2019) Min Kyu Kang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA

(2019) Karn Wijarnpreecha et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice

(2019) Daniel Lindén et al.   Molecular Metabolism

Sarcopenia in cirrhosis: from pathogenesis to interventions

(2019) Maryam Ebadi et al.   JOURNAL OF GASTROENTEROLOGY

Sarcopenia and fatty liver disease

(2019) Jung A. Kim et al.   Hepatology International

Relationship between relative skeletal muscle mass and non-alcoholic fatty liver disease: A 7-year longitudinal study

(2018) Gyuri Kim et al.   HEPATOLOGY

Genetics and epigenetics of NAFLD and NASH: Clinical impact

(2018) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Pitfalls in the measurement of muscle mass: a need for a reference standard

(2018) Fanny Buckinx et al.   Journal of Cachexia Sarcopenia and Muscle

Age-Related Decrease in Skeletal Muscle Mass Is An Independent Risk Factor for Incident NAFLD: A 10-Year Retrospective Cohort Study

(2018) Min Jung Lee et al.   Gut and Liver

Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals

(2017) Bo Kobberø Lauridsen et al.   EUROPEAN HEART JOURNAL

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

(2017) Bo Kyung Koo et al.   JOURNAL OF HEPATOLOGY

Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey

(2016) Hee Yeon Kim et al.   Hepatobiliary & Pancreatic Diseases International

Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011)

(2016) Yong-ho Lee et al.   HEPATOLOGY

Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium

(2016) Yeonjung Kim et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

PNPLA3 gene in liver diseases

(2016) Eric Trépo et al.   JOURNAL OF HEPATOLOGY

10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study

(2016) Jung Hun Ohn et al.   Lancet Diabetes & Endocrinology

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Clarification of the Number of References and Studies Used in Review

(2015)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011)

(2015) Yong-ho Lee et al.   JOURNAL OF HEPATOLOGY

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

(2014) Julia Kozlitina et al.   NATURE GENETICS

Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study

(2013) Ho Cheol Hong et al.   HEPATOLOGY

Adiposity, Muscle Mass, and Muscle Strength in Relation to Functional Decline in Older Persons

(2012) Laura A. Schaap et al.   EPIDEMIOLOGIC REVIEWS

Pathophysiology guided treatment of nonalcoholic steatohepatitis

(2012) Tuyet A T Nguyen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

(2009) Jeong-Hoon Lee et al.   DIGESTIVE AND LIVER DISEASE

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

(2008) Stefano Romeo et al.   NATURE GENETICS